• 1
    Simmons PJ, Levesque JP, Zannettino AC. Adhesion molecules in haemopoiesis. Baillieres Clin Haematol 1997; 10: 485505.
  • 2
    Chan JY, Watt SM. Adhesion receptors on haematopoietic progenitor cells. Br J Haematol 2001; 112: 541557.
  • 3
    Levesque JP, Takamatsu Y, Nilsson SK, et al. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001; 98: 12891297.
  • 4
    Watt SM, Chan JY. CD164—a novel sialomucin on CD34+ cells. Leuk Lymphoma 2000; 37: 125.
  • 5
    Zannettino AC, Buhring HJ, Niutta S, et al. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 1998; 92: 26132628.
  • 6
    Watt SM, Butler LH, Tavian M, et al. Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. Blood 2000; 95: 31133124.
  • 7
    Stella CC, Cazzola M, De Fabritiis P, et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995; 80: 367387.
  • 8
    Krause DS, Fackler MJ, Civin CI, et al. CD34: structure, biology, and clinical utility. Blood 1996; 87: 113.
  • 9
    Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369377.
  • 10
    Majdic O, Stöckl J, Pickl WF, et al. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 1994; 83: 12261234.
  • 11
    Healy L, May G, Gale K, et al. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 1995; 92: 1224012244.
  • 12
    Hu MC-T, Chien SL. The cytoplasmic domain of stem cell antigen CD34 is essential for cytoadhesion signaling but not sufficient for proliferation signaling. Blood 1998; 91: 11521162.
  • 13
    Tada J, Omine M, Suda T, et al. A common signaling pathway via syk and lyn tyrosine kinases generated from capping of the sialomucins CD34 and CD43 in immature hematopoietic cells. Blood 1999; 93: 37233735.
  • 14
    Pearce D, Pettengell R, Gordon-Smith EC, et al. Getting closer to the haemopoietic stem cell utilising internal CD34 expression. Exp Hematol 2000; 28(suppl 1):160a.
  • 15
    Watt SM, Buhring HJ, Rappold I, et al. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998; 92: 849866.
  • 16
    Doyonnas R, Yi-Hsin Chan J, Butler LH, et al. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol 2000; 165: 840851.
  • 17
    Chan JY, Lee-Prudhoe JE, Jorgensen B, et al. Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn. J Biol Chem 2001; 276: 21392152.
  • 18
    Pearce D, Pettengell R, Gordon-Smith EC, et al. Intracellular analysis of AC133+ cell subsets. Blood 1999; 94: 132b.
  • 19
    Pearce D, Pettengell R, Gordon-Smith EC, et al. Intracellular CD34 analysis of AC133+ cell subsets. Br J Haematol 2000; 108: 65a.
  • 20
    McGuckin CP, Pearce D, Pizzey A, et al. Identification of emerging CD34 progenitor subsets. Blood 1998; 92: 146b147b.
  • 21
    Forraz N, Pettengell R, Deglesne PA, et al. AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br J Haematol 2002; 119: 516524.
  • 22
    Steen R, Tjonnfjord GE, Gaudernack G, et al. Differences in the distribution of CD34 epitopes on normal haemopoietic progenitor cells and leukaemic blast cells. Br J Haematol 1996; 94: 597605.
  • 23
    Mayani H, Guilbert LJ, Janowska-Wieczoreck A. Biology of the haemopoietic environment. Eur J Haematol 1992; 49: 225233.
  • 24
    Simmons PJ, Haylock DN, Levesque JP. Influence of cytokines and adhesion molecules on hematopoietic cell development. In: SchindlemK, NordonR, eds. Ex Vivo Cell Therapy. London: Academic Press Ltd, 1999:5183.
  • 25
    McGuckin CP, Hayward-Costa C, Pearce D, et al. Electron microscopy reveals the active nature of CD34 positive cell membrane. Blood 2000; 96: 122b.
  • 26
    Pierelli L, Scambia G, Bonanno G, et al. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/– precursors. Br J Haematol 2000; 108: 610620.
  • 27
    de Wynter EA, Buck D, Hart C, et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998; 16: 387396.
  • 28
    Bhatia M. AC133 expression in human stem cells. Leukemia 2001; 15: 16851688.
  • 29
    Sánchez-Mateos P, Campanero MR, del Pozo MA, et al. Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod. Blood 1995; 86: 22282239.
  • 30
    Seveau S, Lopez S, Lesavre P, et al. Leukosialin (CD43, sialophorin) redistribution in uropods of polarized neutrophils is induced by CD43 cross-linking by antibodies, by colchicine or by chemotactic peptides. J Cell Sci 1997; 110: 14651475.